Enlivex Therapeutics
ENLV
ENLV
9 hedge funds and large institutions have $9.47M invested in Enlivex Therapeutics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$4.56M | |
2 | +$2.46M | |
3 | +$1.09M | |
4 |
DA
DSC Advisors
Chicago,
Illinois
|
+$833K |
5 |
SFM
Soros Fund Management
New York
|
+$518K |
Top Sellers
No sellers this quarter